Sunday , May 29 2022

Pregnancy women taking paracetamol could lower child's IQ, increase autism risk



[ad_1]

A new study has now shown that women taking paracetamol during pregnancy risk lowering the child's IQ.

Not only does the study find that taking the drug is also associated with a higher risk of ADHD (attention deficit hyperactivity disorder) and autism.

Researchers from American universities, including Harvard, have analyzed nine studies that examined 150,000 mothers and children altogether.

Their findings conclude that hormone balance in the uterus is altered by the administration of paracetamol, also known as acetaminophen (APAP).

Speaking of this, post-doctorate Ann Z.Bauer said that exposure to APAP is so common that public health implications even a modest increase in adverse neurodevelopmental risk are substantial.

One study found a three-point decrease in IQ for five-year-olds whose mothers took paracetamol to relieve pain without fever.

Other research shows that young people exposed to the drug in the womb have fought with speech.

In particular, this is not the first time scientists have found a link between paracetamol use and delayed speech.

It seems that expectant mothers who take acetaminophen more than six times during their early pregnancy are more likely to have daughters with limited vocabulary, the study found.

Paracetamol is generally available without a prescription and is the most commonly used medicine during pregnancy.

Research has also shown that common analgesics can raise the risk of a child with ADHD by up to 30% and up to 20% for autism when taken by their mothers.

The study, led by Dr. Ilan Matok of the Hebrew University of Jerusalem, analyzed 132,738 pairs of mothers and children from three to 11 years of age.

Watch it. Dr. Matok said that their results suggest an association between prolonged use of acetaminophen and an increased risk of autism and ADHD.

Researchers in these recent findings, published in the journal Hormone and Behavior, said: "The longer duration of APAP use has been associated with an increased risk.

Pregnant women are generally excluded from scientific research and, therefore, the vast majority of medicines have not been adequately studied and the risks to the child are often poorly understood.

[ad_2]
Source link